Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)

Autor: Sun, Roger, Champiat, Stéphane, Dercle, Laurent, Aspeslagh, Sandrine, Castanon, Eduardo, Limkin, Elaine Johanna, Baldini, Capucine, Postel-Vinay, Sophie, Hollebecque, Antoine, Massard, Christophe, Ammari, Samy, Deutsch, Eric, Soria, Jean-Charles, Marabelle, Aurélien, Ferté, Charles
Zdroj: In European Journal of Cancer October 2017 84:202-211
Databáze: ScienceDirect
Externí odkaz: